levodopa has been researched along with Kaposi Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, S; Hayashi, M; Kohyama, J; Miyata, R; Sasaki, T; Shimohira, M | 1 |
1 other study(ies) available for levodopa and Kaposi Disease
| Article | Year |
|---|---|
Low-dose levodopa is effective for laryngeal dystonia in xeroderma pigmentosum group A.
Topics: Adolescent; Dopamine Agents; Dystonia; Female; Humans; Laryngeal Diseases; Larynx; Levodopa; Male; Xeroderma Pigmentosum | 2010 |